A Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced or Metastatic Colorectal Cancer.
Phase of Trial: Phase I
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Capecitabine; Lapatinib; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline
- 10 Jun 2017 Biomarkers information updated
- 13 May 2010 Actual patient number (12) added as reported by ClinicalTrials.gov.
- 13 May 2010 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.